Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation

INTRODUCTION: Prospective studies on rivaroxaban and apixaban have shown the safety and efficacy of direct anticoagulation agents (DOAC)s used peri-procedurally during radiofrequency ablation (RFA) of atrial fibrillation (AF). Studies comparing the two agents have not been performed. METHODS: Consec...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Indian Pacing Electrophysiol J
Auteurs principaux: Pillarisetti, Jayasree, Reddy, Madhu, Vodapally, Mamatha, Annapureddy, Tulasi, Molugu, Maruthsakhi, Atkins, Donita, Bommana, Sudharani, Pimentel, Rhea, Dendi, Raghuveer, Lakkireddy, Dhanunjaya
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020
Sujets:
Practice Guidelines
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7691779/
https://ncbi.nlm.nih.gov/pubmed/32810538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ipej.2020.08.002
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires